Characterization of Lactobacillus reuteri BCLR-42 and Lactobacillus plantarum BCLP-51 as novel dog probiotics with innate immune enhancing properties

  • Kim, Eun Jin (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Kang, Yeong Im (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Bang, Tae Il (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Lee, Myoung Han (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Lee, Sang Won (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Choi, In Soo (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Song, Chang Seon (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Lee, Joong Bok (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University) ;
  • Park, Seung Yong (Laboratory of Veterinary Immunology, College of Veterinary Medicine, Konkuk University)
  • Received : 2016.01.15
  • Accepted : 2016.04.26
  • Published : 2016.06.30


Probiotics that are able to provide beneficial effects on animal health have become important ingredients of dog foods. This study was conducted to characterize the probiotic potentials of two strains, Lactobacillus reuteri BCLR-42 and Lactobacillus plantarum BCLP-51, that were derived from feces of healthy dogs and evaluated based on tolerance to low pH and bile acid, antimicrobial activities, enzyme profiles, sensitivity to antibiotics, and innate immune enhancing potentials. Both strains showed survival of more than 90% at pH 3 and 0.2% bile acid and exhibited broad antimicrobial activities against indicator bacteria. Moreover, both strains showed high sensitivity to antibiotics, except vancomycin, metronidazole, and gentamicin. The alkaline phosphatase was negligible (score 0), whereas they showed strong beta galactosidase activity (score range 5 or 3, respectively). The phagocytosis and oxidative burst activities of canine granulocytes were significantly enhanced in response to both strains. These results show that both strains have the capability to act as probiotics and the potential for application as ingredients in dog foods.



  1. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 2010, 23, 37-46.
  2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72, 248-254.
  3. Brink M, Todorov SD, Martin JH, Senekal M, Dicks LM. The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus. J Appl Microbiol 2006, 100, 813-820.
  4. Bron PA, Tomita S, Mercenier A, Kleerebezem M. Cell surface-associated compounds of probiotic lactobacilli sustain the strain-specificity dogma. Curr Opin Microbiol 2013, 16, 262-269.
  5. Camacho AI, Souza-Reboucas J, Irache JM, Gamazo C. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies. Methods 2013, 60, 264-268.
  6. Cisek AA, Binek M. Chicken intestinal microbiota function with a special emphasis on the role of probiotic bacteria. Pol J Vet Sci 2014, 17, 385-394.
  7. Cuello-Garcia CA, Brozek JL, Fiocchi A, Pawankar R, Yepes-Nunez JJ, Terracciano L, Gandhi S, Agarwal A, Zhang Y, Schunemann HJ. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2015, 136, 952-961.
  8. Dembinski A, Konturek SJ, Thor P. Gastric and pancreatic responses to meals varying in pH. J Physiol 1974, 243, 115-128.
  9. Di Pierro F, Bertuccioli A, Marini E, Ivaldi L. A pilot trial on subjects with lactose and/or oligosaccharides intolerance treated with a fixed mixture of pure and enteric-coated $\alpha$- and $\beta$-galactosidase. Clin Exp Gastroenterol 2015, 8, 95-100.
  10. Gilliland SE, Staley TE, Bush LJ. Importance of bile tolerance of Lactobacillus acidophilus used as a dietary adjunct. J Dairy Sci 1984, 67, 3045-3051.
  11. Grazul H, Kanda LL, Gondek D. Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice. Gut Microbes 2016, 7, 101-114.
  12. Grze kowiak , Endo A, Beasley S, Salminen S. Microbiota and probiotics in canine and feline welfare. Anaerobe 2015, 34, 14-23.
  13. Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol 1994, 176, 260-264.
  14. Heavey PM, Rowland IR. Microbial-gut interactions in health and disease. Gastrointestinal cancer. Best Pract Res Clin Gastroenterol 2004, 18, 323-336.
  15. Helander IM, Mattila-Sandholm T. Permeability barrier of the Gram-negative bacterial outer membrane with special reference to nisin. Int J Food Microbiol 2000, 60, 153-161.
  16. Holst BS, Gustavsson MH, Lilliehook I, Morrison D, Johannisson A. Leucocyte phagocytosis during the luteal phase in bitches. Vet Immunol Immunopathol 2013, 153, 77-82.
  17. Hou C, Zeng X, Yang F, Liu H, Qiao S. Study and use of the probiotic Lactobacillus reuteri in pigs: a review. J Anim Sci Biotechnol 2015, 9, 6-14.
  18. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155, 1451-1463.
  19. Hulston CJ, Churnside AA, Venables MC. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 2015, 113, 596-602.
  20. Kapila R, Sebastian R, Varma D VP, Sharma R, Kapasiya M, Salingati V, Kapila S, Dang AK. Comparison of innate immune activation after prolonged feeding of milk fermented with three species of Lactobacilli. Microbiol Immunol 2013, 57, 778-784.
  21. Klaenhammer TR, Azcarate-Peril MA, Altermann E, Barrangou R. Influence of the dairy environment on gene expression and substrate utilization in lactic acid bacteria. J Nutr 2007, 137 (3 Suppl 2), 748S-750S.
  22. Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003, 38, 165-172.
  23. Lazado CC, Caipang CM. Mucosal immunity and probiotics in fish. Fish Shellfish Immunol 2014, 39, 78-89.
  24. Lee Y, Lee TS. Enhancement in ex vivo phagocytic capacity of peritoneal leukocytes in mice by oral delivery of various lactic-acid-producing bacteria. Curr Microbiol 2005, 50, 24-27.
  25. Maeda K, Sakonju I, Kanda A, Suzuki T, Kakuta T, Shimamura S, Okano S, Takase K. Priming effects of lipopolysaccharide and inflammatory cytokines on canine granulocytes. J Vet Med Sci 2010, 72, 55-60.
  26. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 2005, 140, 417-426.
  27. McCoy S, Gilliland SE. Isolation and characterization of Lactobacillus species having potential for use as probiotic cultures for dogs. J Food Sci 2007, 72, M94-97.
  28. Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 2012, 46 (Suppl), S1-2.
  29. Moretti J, Blander JM. Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes. Curr Opin Immunol 2014, 26, 100-110.
  30. Nilsson M, Weineisen M, Andersson T, Truedsson L, Sjobring U. Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum. Eur J Immunol 2005, 35, 1472-1481.
  31. Oh C, Lee K, Cheong Y, Lee SW, Park SY, Song CS, Choi IS, Lee JB. Comparison of the oral microbiomes of canines and their owners using next-generation sequencing. PLoS One 2015, 10, e0131468.
  32. Paturi G, Phillips M, Kailasapathy K. Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J Food Prot 2008, 71, 796-801.
  33. Perelmuter K, Fraga M, Zunino P. In vitro activity of potential probiotic Lactobacillus murinus isolated from the dog. J Appl Microbiol 2008, 104, 1718-1725.
  34. Rabiu BA, Jay AJ, Gibson GR, Rastall RA. Synthesis and fermentation properties of novel galacto-oligosaccharides by $\beta$-galactosidases from Bifidobacterium species. Appl Environ Microbiol 2001, 67, 2526-2530.
  35. Reid G. Friendship R. Alternatives to antibiotic use: probiotics for the gut. Anim Biotechnol 2002, 13, 97-112.
  36. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int 2015. Epub ahead of print. doi: 10.1155/2015/505878.
  37. Sanchez de Medina F, Martinez-Augustin O, Gonzalez R, Ballester I, Nieto A, Galvez J, Zarzuelo A. Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem Pharmacol 2004, 68, 2317-2326.
  38. Schmitz S, Henrich M, Neiger R, Werling D, Allenspach K. Comparison of $TNF{\alpha}$ responses induced by Toll-like receptor ligands and probiotics Enterococcus faecium in whole blood and peripheral blood mononuclear cells of healthy dogs. Vet Immunol Immunopathol 2013, 153, 170-174.
  39. Stoyanovski S, Gacovski Z, Antonova-Nikolova S, Kirilov N, Ivanova I, Tenev T, Hadjinesheva V. API ZYM enzymatic profile of lactic acid bacteria isolated from traditional Bulgarian meat product "Lukanka". Bulg J Agric Sci 2013, 19 (Suppl 2), 86-89.
  40. Strompfova V, Laukova A. Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates. Anaerobe 2014, 29, 108-112.
  41. Teuber M, Meile L, Schwarz F. Acquired antibiotic resistance in lactic acid bacteria from food. Antonie Van Leeuwenhoek 1999, 76, 115-137.
  42. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol 2014, 20, 7878-7886.

Cited by

  1. Oral administration of bacteriocin-producing and non-producing strains of Enterococcus faecium in dogs vol.103, pp.12, 2016,
  2. Evaluation of Weissella Cibaria JW15 Probiotic Derived from Fermented Korean Vegetable Product Supplementation in Diet on Performance Characteristics in Adult Beagle Dog vol.9, pp.8, 2016,
  3. Invited review: Characterization of new probiotics from dairy and nondairy products—Insights into acid tolerance, bile metabolism and tolerance, and adhesion capability vol.104, pp.8, 2016,